Quick Answer
Aardvark Therapeutics, Inc. reported Total Assets of $117.18 million for fiscal year 2025.
Aardvark Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $117.18M | +51.2% |
| 2024 | $77.51M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $133.23M | — | -9.7% |
| June 30, 2025 | $147.47M | — | -6.1% |
| March 31, 2025 | $157.03M | — | +102.6% |
| December 31, 2024 | $77.51M | — | — |
- Aardvark Therapeutics, Inc. showed an increase of +51.2% in Total Assets compared to the prior fiscal year.
- Over the 2024–2025 period, Aardvark Therapeutics, Inc.’s total assets has grown by 51.2% (from $77.51 million to $117.18 million).
- The most recent figure is from Aardvark Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: